Beranda › Skizofrenia › Illinois › Chicago
Uji klinis Skizofrenia di Chicago, IL
21 studi untuk Skizofrenia mencari peserta di lokasi sekitar Chicago (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium (CNTRACS): Study 1
Menerima pesertaSukarelawan sehat diterima
- The University of Chicago, Chicago
A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia
Menerima pesertaFase 1
- Uptown Research Institute, Chicago
Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
Menerima pesertaFase 3
- Local Institution - 0067, Chicago
- Pillar Clinical Research -Chicago, Chicago
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
Menerima pesertaFase 3
- Neurocrine Clinical Site, Chicago
A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
Menerima pesertaFase 3
- Local Institution - 0175, Chicago
- EmVenio Research Center - Prime Healthcare, Chicago
A Study of Brenipatide in Adult Participants With Schizophrenia
Menerima pesertaFase 2
- Re:Cognition Health - Chicago, Chicago
52-week Open Label Safety-Tolerability Study
Menerima pesertaFase 3
- Pillar Clinical Research, Chicago
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
Menerima pesertaFase 3
- Local Institution - 0122, Chicago
- EmVenio Research Center - Prime Healthcare, Chicago
A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT
Menerima pesertaFase 1
- Uptown Research Institute, Chicago
A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
Menerima pesertaFase 2
- Clinical Site, Chicago
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
Menerima pesertaFase 3
- Alkermes Investigator Site, Chicago
Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia
Menerima pesertaFase 2
- Uptown Research Institute LLC, Chicago
- Pillar Clinical Research LLC, Chicago
Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia
Menerima pesertaFase 3
- Pillar Clinical Research, Chicago
A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia
Menerima pesertaFase 2
- Uptown Research Institute, Chicago
A Study to Evaluate the Effect of KarXT on Urological Safety
Menerima pesertaFase 4
- Uptown Research Institute, Chicago
- Pillar Clinical Research -Chicago, Chicago
CLOZAPINE Response in Biotype-1
Menerima pesertaFase 4
- University of Chicago, Chicago
Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
Menerima pesertaStudi observasional
- University of Chicago Medical Center, Chicago
NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
Menerima pesertaFase 3
- Neurocrine Clinical Site, Chicago
Randomized Withdrawal Study in Patients With Schizophrenia
Menerima pesertaFase 3
- Vanda Investigational Site, Chicago
Study of ALTO-101 in Patients With Schizophrenia
Menerima pesertaFase 2
- Site 5056, Chicago
Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
Menerima pesertaFase 3Sukarelawan sehat diterima
- Reviva site, Chicago
Uji klinis Skizofrenia di kota lain
- Atlanta, GA22 studi
- Little Rock, AR19 studi
- Hollywood, FL15 studi
- Boston, MA14 studi
- Houston, TX13 studi
- San Diego, CA13 studi
- Hialeah, FL13 studi
- New York City, NY13 studi
- Austin, TX13 studi
- Garden Grove, CA12 studi
- Germantown, MD11 studi
- Miami, FL10 studi
Studi lain di Chicago
- Kanker Paru Non-Sel Kecil61 studi
- Kanker Payudara58 studi
- Kanker (semua jenis)51 studi
- Kanker Metastatik45 studi
- Kanker Prostat45 studi
- Obesitas41 studi
- Kanker Paru41 studi
- Kanker Ovarium36 studi
- Stroke34 studi
- Kanker Kolorektal33 studi
- Gagal Jantung31 studi
- Kelebihan Berat Badan28 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.